Similar articles for PMID: 35346931

Year	Number of Results
2020	25
2021	52
2022	56
2023	14
2024	0

1

Best Practices for COVID-19 Mass Vaccination Clinics.

Shakory S, Eissa A, Kiran T, Pinto AD. Shakory S, et al. Ann Fam Med. 2022 Mar-Apr;20(2):149-156. doi: 10.1370/afm.2773. Ann Fam Med. 2022. PMID: 35346931 Free PMC article.

2

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.

Frederiksen LSF, Zhang Y, Foged C, Thakur A. Frederiksen LSF, et al. Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020. Front Immunol. 2020. PMID: 32793245 Free PMC article. Review.

3

Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.

Chen JM, Sun YX, Chen JW. Chen JM, et al. J Med Virol. 2020 Nov;92(11):2453-2457. doi: 10.1002/jmv.26162. Epub 2020 Jun 29. J Med Virol. 2020. PMID: 32525587 Free PMC article. Review.

4

Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Chaudhary JK, Yadav R, Chaudhary PK, Maurya A, Kant N, Rugaie OA, Haokip HR, Yadav D, Roshan R, Prasad R, Chatrath A, Singh D, Jain N, Dhamija P. Chaudhary JK, et al. Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.

5

[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].

National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732. Zhonghua Liu Xing Bing Xue Za Zhi. 2021. PMID: 34814607 Chinese.

6

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Free article. Review.

7

Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.

Signorelli C, Odone A, Gianfredi V, Capraro M, Kacerik E, Chiecca G, Scardoni A, Minerva M, Mantecca R, Musarò P, Brazzoli P, Basteri P, Bertini B, Esposti F, Ferri C, Alberti VA, Gastaldi G. Signorelli C, et al. Ann Ig. 2021 Sep-Oct;33(5):499-512. doi: 10.7416/ai.2021.2456. Epub 2021 Jun 11. Ann Ig. 2021. PMID: 34113956 Free article.

8

Travel-related control measures to contain the COVID-19 pandemic: a rapid review.

Burns J, Movsisyan A, Stratil JM, Coenen M, Emmert-Fees KM, Geffert K, Hoffmann S, Horstick O, Laxy M, Pfadenhauer LM, von Philipsborn P, Sell K, Voss S, Rehfuess E. Burns J, et al. Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717. Cochrane Database Syst Rev. 2020. PMID: 33502002 Updated.

9

Impact of vaccination on the COVID-19 pandemic in U.S. states.

Chen X, Huang H, Ju J, Sun R, Zhang J. Chen X, et al. Sci Rep. 2022 Jan 28;12(1):1554. doi: 10.1038/s41598-022-05498-z. Sci Rep. 2022. PMID: 35091640 Free PMC article.

10

Network models to evaluate vaccine strategies towards herd immunity in COVID-19.

Tetteh JNA, Nguyen VK, Hernandez-Vargas EA. Tetteh JNA, et al. J Theor Biol. 2021 Dec 21;531:110894. doi: 10.1016/j.jtbi.2021.110894. Epub 2021 Sep 9. J Theor Biol. 2021. PMID: 34508758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year